Prospective Cohort of Advanced and Metastatic Non-Small Cell Lung Cancer Patients with EGFR Mutations: Long-Term Survival and Other Outcomes After First Line Osimertinib
Not Applicable
- Conditions
- on-small Cell Lung Cancer
- Registration Number
- JPRN-UMIN000042961
- Lead Sponsor
- IQVIA Solutions Japan K.K.,Real World Evidence Solutions/HEOR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method